Abstract |
We studied the activity of the combination of sulbactam and ceftriaxone against a Klebsiella pneumoniae strain producing TEM-3, a new extended-broad-spectrum beta-lactamase, in an endocarditis model. In vitro, ceftriaxone was strongly inactivated in the presence of TEM-3 (MBC, 128 micrograms/ml with an inoculum of 5 x 10(5) CFU/ml). A marked inoculum effect was demonstrated with sulbactam: effective concentrations of inhibitor needed to reduce the MIC and MBC of ceftriaxone to similar levels increased from 1 microgram/ml in the presence of an inoculum of 5 x 10(5) CFU/ml to 20 micrograms/ml in the presence of an inoculum of 1 x 10(7) CFU/ml. In vivo, sulbactam given at 200 mg/kg of body weight every 12 h, a dosage higher than that previously reported to be effective against rabbit endocarditis caused by other microorganisms, was not sufficient to restore the complete activity of ceftriaxone given at 30 mg/kg once daily for 4 days. This insufficient activity may be correlated with the presence of a high level of beta-lactamase inside the vegetations, as indicated by a quantitative in vitro assay of beta-lactamase activity in the cardiac vegetation, suggesting an insufficient inactivation of the extended-broad-spectrum beta-lactamase in vivo.
|
Authors | F Caron, L Gutmann, A Bure, B Pangon, J M Vallois, A Pechinot, C Carbon |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 34
Issue 11
Pg. 2070-4
(Nov 1990)
ISSN: 0066-4804 [Print] United States |
PMID | 2073099
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ceftriaxone
- beta-Lactamases
- Sulbactam
|
Topics |
- Animals
- Ceftriaxone
(pharmacokinetics, therapeutic use)
- Drug Resistance, Microbial
- Drug Therapy, Combination
(therapeutic use)
- Endocarditis, Bacterial
(drug therapy, microbiology)
- Female
- Half-Life
- Klebsiella Infections
(drug therapy, microbiology)
- Klebsiella pneumoniae
(drug effects, enzymology)
- Microbial Sensitivity Tests
- Rabbits
- Sulbactam
(pharmacokinetics, therapeutic use)
- beta-Lactamases
(metabolism)
|